Reaction
Injection Site Pustule reporting signals
As of the last recalculation, Injection Site Pustule appears in 374 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is CABOTEGRAVIR (PRR 27.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Cabotegravir | 4 | 27.9 | 27.9 |
| Treprostinil | 40 | 19.7 | 19.8 |
| Naltrexone | 10 | 18.5 | 18.5 |
| Tirzepatide | 22 | 8.0 | 8.0 |
| Galcanezumab-Gnlm | 4 | 7.1 | 7.1 |